USPTO 2015–2025 USPTO PatentsView US Corporation

NeuMoDx Molecular, Inc.

USPTO PatentsView assignee record - 30 granted patents across 14 technology areas, recorded in grant years 2015–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: B01L (Chemical OR Physical Laboratory Apparatus FOR General USE).

RSS updates for this company

The verdict

According to USPTO PatentsView, Neumodx ranks #10,407 of 49,997 tracked US assignees by granted-patent volume, with 30 patents across 14 technology areas.

#10,407
of 49,997 US assignees by volume
Top 21%
by Innovation Score (46.5/100)
17.9
avg claims per patent
-42%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R10407 · US Corporation #10,407 · 30 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-USCORP · VEL-DROP · BOOK-FULL

  • GRANTS-SMALL 30 grants
  • UPPER-Q #10,407/49,997
  • PHOTO-FINISH National Institute…
  • CPC-FOCUS B01L · 14 areas
  • INNOV-PAR 46.5/100
  • CLAIMS-RICH 17.9 claims/avg
  • TYPE-USCORP US Corporation
  • VEL-DROP -42% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: National Institute OF Metrology, China (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Neumodx’s 46.5 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Innovation-score neighbourhood around Neumodx

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Neumodx's Innovation Score is 46.5/100 (top 21% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Does more volume mean deeper claims for Neumodx?

Each dot is one of Neumodx’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Neumodx’s own 17.9 claims/patent is ABOVE the 9.5 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Neumodx vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView. 2×2 strategic matrix plotting 9 entities by Granted patents (volume) (X) and Avg claims / patent (Y), with a crosshair dividing the plot into four quadrants. Volume + depthSelective & thoroughVolume over depthLean filer 29.93030.1 0510152025 Granted patents (volume) Avg claims / patent National Institute OF Metrology, China - 30, 9.53National Institut…Nippon Closures Co., Ltd - 30, 8.4Nippon ClosuresNoven Pharmaceuticals, Inc. - 30, 19.8Noven Pharmaceuti…Nucletron Operations B.V. - 30, 16.83Nucletron Operati…Nevis Industries LLC - 30, 14.3Nevis IndustriesNo Longer Naked Lures, LLC - 30, 1No Longer Naked L…Nokian Heavy Tyres Ltd - 30, 1Nokian Heavy TyresNorth-West University - 30, 10.5North-west Univer…NeuMoDx Molecular, Inc. - 30, 17.87Neumodx Molecular
Neumodx vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Neumodx's grants concentrate

NeuMoDx Molecular, Inc. is a focused PatentsView assignee: 14 CPC subclasses with 100% of grants classified under B01L (Chemical OR Physical Laboratory Apparatus FOR General USE). Peak complete grant year is 2016 (7 grants) versus a trough of 1 in 2021. By volume, Neumodx sits between National Institute OF Metrology, China and North-West University.

Neumodx's three-year grant acceleration

NeuMoDx Molecular, Inc. shows 8 grants in 2022–2024 against only 5 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Who files at NeuMoDx's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows NeuMoDx holds 30 patents at rank #10,410, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near NeuMoDx

By rank, the assignees closest to #10,410 in granted patent volume.

Leaders in B01L (Chemical OR Physical Laboratory Apparatus FOR General USE)

Other assignees with the most granted patents in NeuMoDx's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for NeuMoDx, neither rank-band nor same-CPC leaders (those blocks stay above). In B01L (Chemical OR Physical Laboratory Apparatus FOR General USE), NeuMoDx ranks #61 of 1,325 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (46 here).

Neumodx's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

46 Top 21% higher than 79% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

02468 2015201620172018201920202021202220232024 1
USPTO utility patent grants by year · 2015–2024

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table
NeuMoDx Molecular, Inc. patent grants by year, 2015–2025
Year Patents Granted Share of Period
2015 2 6.7%
2016 7 23.3%
2017 5 16.7%
2018 3 10.0%
2019 2 6.7%
2020 2 6.7%
2021 1 3.3%
2022 3 10.0%
2023 4 13.3%
2024 1 3.3%

Which technologies does NeuMoDx Molecular, Inc. patent most?

Top 14 of 14 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

What to do with this data

NeuMoDx Molecular, Inc.'s patent record in context - here's where to go next.

  • NeuMoDx Molecular, Inc.'s lead technology class is B01L (Chemical OR Physical Laboratory Apparatus FOR General USE), 100% of its portfolio - see every assignee active in that class. Explore B01L
  • Ranked #10,407 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare NeuMoDx Molecular, Inc. against National Institute OF Metrology, China, an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 46.5/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.